Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Prevention and Treatment of Illicit Substance Use

Université de Montréal

$89,816.00

The clinical and biological correlates of cannabis craving in schizophrenia, and its treatment with trans-cranial magnetic stimulation

FY 2009-10

Summary
During the 1990s, cannabis smoking has been on the rise among teenagers and young adults in Canada. In the general population, about 10% of those who try cannabis may develop a substance use disorder (abuse or dependence). The likelihood of developing a cannabis use disorder is increased by 3 to 5 times for those who suffer from schizophrenia, one of the most disabling psychiatric disorders. Drug craving (desire) is among the leading contributors to drug relapse. Interestingly, pilot studies have shown that schizophrenia patients experience increased craving for cocaine, compared to non-psychosis substance abusers. It remains to be determined whether this is true for cannabis. In the current research proposal, we will test the hypothesis that schizophrenia patients experience increased craving in response to cue-evoked cannabis smoking, compared to non-psychosis abusers. We will also examine the neural (functional brain imaging) and biological (endogenous cannabinoids) correlates of cannabis craving in these patients. As a secondary objective, we will explore (for the first time) the usefulness of trans-cranial magnetic stimulation as a potential treatment of cannabis craving in both groups of cannabis abusers. The current proposal promises not only to provide a better understanding of cannabis craving in psychosis and non-psychosis patients, but also to provide an opportunity to gather pilot data about the clinical utility of technologic interventions for the treatment of cannabis abuse/dependence.
Program
Catalyst Grant: Prevention and Treatment of Illicit Substance Use
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
191747
Name
Potvin Stéphane
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Catalyst Grant: Prevention and Treatment of Illicit Substance Use
Projecttitle
The clinical and biological correlates of cannabis craving in schizophrenia, and its treatment with trans-cranial magnetic stimulation
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$89,816
Cihrequipment2
$0
Programname2
Catalyst Grant: Prevention and Treatment of Illicit Substance Use
Keyworddelim
Cannabis; Endogenous Cannabinoids; Functional Magnetic Resonance Imaging; Schizophrenia; Trans-Cranial Magnetic Stimulation
Abstract
During the 1990s, cannabis smoking has been on the rise among teenagers and young adults in Canada. In the general population, about 10% of those who try cannabis may develop a substance use disorder (abuse or dependence). The likelihood of developing a cannabis use disorder is increased by 3 to 5 times for those who suffer from schizophrenia, one of the most disabling psychiatric disorders. Drug craving (desire) is among the leading contributors to drug relapse. Interestingly, pilot studies have shown that schizophrenia patients experience increased craving for cocaine, compared to non-psychosis substance abusers. It remains to be determined whether this is true for cannabis. In the current research proposal, we will test the hypothesis that schizophrenia patients experience increased craving in response to cue-evoked cannabis smoking, compared to non-psychosis abusers. We will also examine the neural (functional brain imaging) and biological (endogenous cannabinoids) correlates of cannabis craving in these patients. As a secondary objective, we will explore (for the first time) the usefulness of trans-cranial magnetic stimulation as a potential treatment of cannabis craving in both groups of cannabis abusers. The current proposal promises not only to provide a better understanding of cannabis craving in psychosis and non-psychosis patients, but also to provide an opportunity to gather pilot data about the clinical utility of technologic interventions for the treatment of cannabis abuse/dependence.
Competitiondate
200911
Approvedterm2
1 yr 0 mth
Pinamesdelim
Potvin, Stéphane
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $89,816~ $0~
Université de Montréal - $89,816 Grant (2009-10) | Canada Spends